<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1635163/" ref="ordinalpos=768&amp;ncbi_uid=806347&amp;link_uid=PMC1635163" image-link="/pmc/articles/PMC1635163/figure/F9/" class="imagepopup">Figure 9. Proposed model of the role of TRPC6 in the calcineurin-NFAT <span class="highlight" style="background-color:">pathway</span> in vivo..  From: TRPC6 fulfills a calcineurin <span class="highlight" style="background-color:">signaling</span> circuit during pathologic cardiac remodeling. </a></div><br /><div class="p4l_captionBody">TRPC6 gene transcription is activated by the calcineurin-NFAT pathway, and an increase in the expression of TRPC6 further activates the calcineurin-NFAT pathway. The Î²-MHC gene is one of the downstream targets of this pathway, and its expression may alter cardiac contractility. Activation of BNP expression also provides a negative feedback loop to curtail hypertrophic signaling. TRPC6 forms a positive regulatory circuit in calcineurin-NFAT pathways leading to pathologic remodeling. DAG, diacylglycerol; GATA, GATA-binding protein; IP3, inositol-1,4,5-triphosphate; PLC, phospholipase C.                </div></div>